The human DEK proto-oncogene has been found to play an important role in autoimmune disease, viral infection and human carcinogenesis. Although it is transcriptionally up-regulated in cervical cancer, its intracellular function and regulation is still unexplored. In the present study, DEK and IκBα [inhibitor of NF-κB (nuclear factor κB) α] shRNAs (short hairpin RNAs) were constructed and transfected into CaSki cells using Lipofectamine TM . The stable cell line CaSki-DEK was obtained after G418 selection. CaSki-IκB cells were observed at 48 h after psiRNA-IκB transfection. The inhibitory efficiency of shRNAs were detected by RT (reverse transcription)-PCR and Western blot analysis. The proliferation activity of cells were measured using an MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide] assay, cell apoptosis was measured using an Annexin V/PI (propidium iodide) kit, the cell cycle was analysed by flow cytometry and cell senescence was detected using senescence β-galactosidase staining. The intracellular expression of NF-κB p65 protein was studied by cytochemistry. The expression levels of NF-κB p65, p50, c-Rel, IκBα and phospho-IκBα protein were analysed by immunoblotting in whole-cell lysates, cytosolic fractions and nuclear extracts. The protein expression and activity of p38 and JNK (c-Jun N-terminal kinase) were also assayed. In addition, the NF-κB p65 DNA-binding activity was measured by ELISA. Following the silencing of DEK and IκBα, cell proliferation was inhibited, apoptosis was increased, the cell cycle was blocked in the G 0 /G 1 -phase with a corresponding decrease in the G 2 /M-phase, and cell senescence was induced. All of these effects may be related to the up-regulation of NF-κB p65 expression and its nuclear translocation.
INTRODUCTION
Apoptosis and senescence act as two basic cellular protective mechanisms from cancer development [1] . Any disruption in them could eventually lead to benign proliferative lesions, even malignant tumours. DEK overexpression could inhibit both apoptosis and senescence in HeLa cervical cancer cells. It acts as an inhibitor of apoptosis and senescence in cultured primary cells and cancer cell lines [2] . Regulation of apoptosis and senescence is a complex process requiring a number of proteins and many signalling pathways. It has been found that inhibition of apop- Abbreviations used: CREB, cAMP-response-element-binding protein; DTT, dithiothreitol; HPV, human papillomavirus; HRP , horseradish peroxidase; JNK, c-Jun N-terminal kinase; MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide; NF-κB, nuclear factor κB; IκB, inhibitor of NF-κB; P/CAF, p300/CREB-binding protein-associated factor; PI, propidium iodide; RNAi, RNA interference; RT, reverse transcription; shRNA, short hairpin RNA; siRNA, small interfering RNA; TBS, Tris-buffered saline 1 These authors contributed equally to the study. 2 To whom correspondence should be addressed (email lhb981024@hotmail.com).
tosis by DEK occurs via the destabilization of p53 and activation of downstream apoptosis inducers [3] . The up-regulation of retinoblastoma protein as a senescence mediator also contributes to senescence induced by the repression of DEK [4] . Findings have shown that long-term DEK down-regulation results in premature senescence in a variety of melanoma cell lines, whereas short-term inhibition of DEK expression attenuates the resistance to DNA-damaging agents [5] . In contrast with previous studies is the finding that DEK shRNA (short hairpin RNA) has no effect on p53 levels or p53-dependent apoptosis, but selectively activates the transcription of MCL-1 (myeloid cell leukaemia sequence 1) [5] . The difference in regulation depends on the intracellular expression of DEK. Identification of gene-regulatory programmes and comparisons between DEK-depleted senescent and apoptotic cells may yield important information about p53-driven or p53-independent pathways. In response to DEK depletion, the regulation of approximately 700 genes was accompanied by senescence in HeLa cells [6] , thus the status of other genetic programmes, especially the cellular transcriptome, may be crucial to the potential transcriptional roles of DEK.
In mammalian cells, the NF-κB (nuclear factor κB) pathway is a critical signal transduction system and functions as a key regulator in cell apoptosis and senescence [7] . Much evidence has demonstrated that the aberrant activation of NF-κB is concerned with cervical carcinogenesis [8] . It has been established that DEK could inhibit p65-mediated transcriptional activation in a concentration-dependent manner and play an important role in many nuclear processes [9] . DEK enriches transcriptionally active chromatin combined with specific transcription complexes, and has a dual role implicated as a transcriptional co-activator and co-repressor [10] . In addition, the proteomic analysis of apoptosis-related proteins regulated by DEK showed that more proteins with oxidoreductase activity were significantly up-regulated in DEK shRNA-transfected HeLa cells [5] . The oxidative stress regulated by oxidoreductase-related proteins is a frequent stimulus of the NF-κB pathway [11] . On the basis of the cross-talk between DEK and the NF-κB pathway, we hypothesize that NF-κB may interfere with the regulation of DEK in the induction of apoptosis and senescence in cervical cancer.
In our present study, a plasmid-based shRNA (short hairpin RNA) targeting the DEK gene was constructed and transfected into CaSki cells to explore its effect on apoptosis and senescence. Furthermore, research on NF-κB pathways should allow insights into the mechanism of apoptosis and senescence regulated by DEK. A better understanding of the downstream cellular pathways regulated by DEK and how they influence apoptosis compared with senescence will be important for the clinical diagnosis and treatment of cervical cancer.
MATERIALS AND METHODS

Cell culture
The HPV (human papillomavirus)-positive human cervical carcinoma cell line CaSki was obtained from the Cancer Institute of Beijing and was maintained in DMEM (Dulbecco's modified Eagle's medium) supplemented with 10 % FBS (fetal bovine serum) (Invitrogen), 100 units/ml penicillin and 100 μg/ml streptomycin at 37
• C in a humidified atmosphere of 5 % CO 2 .
DEK and IκB (inhibitor of NF-κB) α shRNA construction Two complementary oligonucleotides specifically homologous with the 639-659 bp of human DEK cDNA and 1417-1437 bp of IκBα cDNA were designed with the online tool siRNAWizard and were synthesized by Sangon, and were separated by a short spacer region of 7 nt (TCAAGAG). Homology analysis was made using NCBI Blast. The sequences are as follows: DEK sense strand, 5 -ACCTCGAGCATCTGTGAGGTTCTTGATCAAGAGTCAA-GAACCTCACAGATGCTCTT-3 ; antisense strand, 5 -CAAA-AAGAGCATCTGTGAGGTTCTTGACTCTTGATCAAGAAC-CTCACAGATGCTCG-3 ; IκBα sense strand, 5 -ACCTCGG-AGTGTTAAGCGTTCAGTGATCAAGAGTCACTGAACGC-TTAACACTCCTT-3 ; antisense strand, 5 -CAAAAAGGA-GTGTTAAGCGTTCAGTGACTCTTGATCACTGAACGCTT-AACACTCCG-3 .
The plasmid psiRNA-hH1neoG2 (Invitrogen) was digested with BbsI and was eluted using a 0.7 % low-melting-point agarose gel. The purified DNA fragment was diluted to obtain a solution at 0.1 μg/μl for constructing siRNA plasmid. Equal amounts inserts were annealed and cloned into the BbsI site, which is downstream of the human H1 promoter in the plasmid. The recombinant plasmids, named as psiRNA-hH1DEK and psiRNA-IKB, were transformed into Escherichia coli GT116-competent cells and selected on a Kan XGal agar plate (Invitrogen) by the white/blue selection. Plasmid DNA was extracted from white clones and confirmed on a 3 % agarose gel electrophoresis after restriction enzyme digestion with SpeI/AvrII. The constructed vectors were also verified by DNA sequencing.
Cell transfection
psiRNA-hH1DEK and psiRNA-hH1neoG2 were transfected using Lipofectamine TM 2000 (Invitrogen), according to the manufacturer's instructions. Stable cell lines were selected with G418 and were called CaSki-DEK and CaSki-neo. psiRNA-IκB was transfected into CaSki cells as above and were observed at 48 h after transfection, and are referred to CaSki-IκB cells. Untransfected CaSki cells and CaSki-neo were used as the control groups.
RT (reverse transcription)-PCR
Total RNA were extracted using TRIzol ® reagent (Life Technologies) and reverse-transcribed using a SuperScript TM III First-Strand Synthesis kit (Invitrogen). cDNA (1 μl) was denatured and PCR-amplified with KOD FX DNA polymerase (Toyobo). β-Actin was chosen as the reference gene. The primers were as follows: DEK forward primer, 5 -AGGCACTGTGTCCTCATTAA-3 ; reverse primer, 5 -TCTGACAGAATTTCAGGACA-3 (332 bp); IκBα forward primer, 5 -CGGCCTGGACTCCATGAAAGACG-3 ; reverse primer, 5 -GGGCAGTCCGGCCATTACAGG-3 (566 bp); and β-actin forward primer, 5 -GTGGGCCGCTCTAGGCACCAA-3 ; reverse primer, 5 -CTCTTTGATGTCACGCACGATTTC-3 (700 bp). A total of 35 cycles were carried out of denaturation for 15 s at 94
• C, annealing for 30s at 60
• C, and extension for 1 min at 72
• C, followed by incubation for an additional 5 min at 72
• C. PCR products were resolved on 2 % agarose gels and band intensities were analysed using Fluorchem 
Western blot analysis
Cells were lysed with RIPA buffer [50 mM Tris/HCl (pH 7.4), 150 mM NaCl, 1 % Triton X-100, 0.25 % sodium deoxycholate, 0.1 % SDS, 1mM PMSF and 0.1mM leupeptin] and were kept for 30 min on ice. Total proteins were collected following centrifugation at 15 000 g for 20 min at 4
• C and were quantified in triplicate using a DC protein assay (Bio-Rad Laboratories). Cytosolic proteins were extracted with lysis buffer [50 mM Hepes (pH 7.4), 5 mM NaCl, 3 mM MgCl 2 , 1 mM KCl, 1 mM DTT (dithiothreitol), 0.5 μg/ml leupeptin and 20 μM PMSF] and were centrifuged at 14 000 g for 10 min at 4
• C. Nuclear proteins were extracted as follows: first the cells were lysed in 400 μl of ice-cold buffer A [10 mM Hepes, pH 7.4, 1.5 mM MgCl 2 , 10 mM KCl, 0.5 mM DTT and 0.2 mM PMSF] on ice for 15 min, transferred to a new microcentrifuge tube and vortex-mixed for 10 s, and then centrifuged at 14 000 g for 3 min at 4
• C. Cell pellets were collected and resuspended with 80 μl of ice-cold buffer B [20 mM Hepes, pH 7.4, 1.5 mM MgCl 2 , 420 mM NaCl, 0.2 mM EDTA, 25 % glycerol, 0.5 mM DTT and 0.2 mM PMSF] on ice for 50 min.The tubes were agitated gently every 15 min and centrifuged at 14 000 g for 5 min at 4
• C. After electrophoresis by SDS/PAGE (4-12 % gel), proteins were transferred on to a PVDF membrane at 15 V for 30 min using a semi-dry electrotransfer system. Membranes were blocked in TBS (Tris-buffered saline) containing 0.1 % Tween and 5 % non-fat milk, and then incubated overnight at 4
• C with primary antibodies against DEK, IκBα, NF-κB p65, NF-κB p50, phospho-IκBα, c-Rel, p38, JNK (c-Jun N-terminal kinase) and β-actin. An anti-lamin B antibody was chosen as a nuclear internal control. Immunoblots were developed with an HRP (horseradish peroxidase)-labelled goat anti-(rabbit IgG) secondary antibody for 1 h and detected with ECL (enhanced chemiluminescence) reagents (Santa Cruz Biotechnology). The activities of p38 and JNK were measured using kinase assay kits (Cell Signaling Technology) using ATF-2 (activating transcription factor-2) and c-Jun as the substrates respectively. Phosphorylation was detected with anti-phospho antibodies by immunoblotting. Densitometric analysis was quantified using Fluorchem V 2.0 software.
Cells were digested with 0.25 % trypsin and resuspended at a concentration of 5×10 4 cells/ml in fresh medium and 200 μl aliquots were seeded into 96-well plates and allowed to grow for 7 days. Every day, three wells were chosen for the measurement of growth curve. A portion (20 μl) of fresh medium containing 5 mg/ml MTT (Sigma) was added into each well. After an additional culture for 4 h at 37
• C, formazan was solubilized by the addition of 150 μl of DMSO (Sigma) and shaken horizontally for 10 min. The absorbance values were measured at 570 nm using an automatic microplate reader (TECAN) in triplicate and repeated three times per group.
Annexin V/PI (propidium iodide) staining for apoptosis
Cells apoptosis was measured with an Annexin V-FITC apoptosis detection kit (BD Biosciences). Cells was resuspended in binding buffer [10 mM Hepes (pH 7.4), 140 mM NaOH and 2.5 mM CaCl 2 ] at a concentration of 10 6 cells/ml. Annexin V-FITC (5 μl) was added, vortex-mixed gently and incubated for 15 min at 4
• C in the dark. Cells were stained with 10 μl of PI for another 5 min at 4
• C in the dark. Apoptotic cells were analysed immediately on a flow cytometer (BD Biosciences) with the CellQuest 3.0 software system.
Cell cycle analysis by flow cytometry
Cells were harvested with 0.25 % trypsin, centrifuged at 1000 g for 10 min and resuspended at 10 6 cells/ml in PBS. RNase A (100 μg/ml) was added and incubated at 37
• C for 30 min. Cells were stained with PI for additional 30 min at 4
• C in the dark. Approximately 10 4 cells were examined in a FACSCaliber flow cytometer, and DNA histograms were analysed by Modfit LT3.0 software.
Senescence β-galactosidase staining
Cells were seeded on to autoclaved coverslips and cultured for 48 h. Senescence β-galactosidase staining (Cell Signaling Technology) was used to detect senescent cells. First, coverslips were fixed with 1 ml of fixative solution for 15 min and the staining solution mixture was added to it. The cells were then incubated overnight at 37
• C. The development of a blue colour was observed, and cells were counterstained with Neutral Red and overlaid with 70 % glycerol. The percentage of positive cells was analysed with microscope with a digital CCD (charged-coupled device) capturing and image analysis system (Olympus BX51/Qimaging Evolution MP 5.5/UIC MetaMorph).
Immunocytochemical staining for NF-κB p65
Cells were cultured as above and coverslips were rinsed with icecold PBS and fixed in ice-cold acetone for 20 min, then treated with 3 % H 2 O 2 in methanol for 15 min to eliminate endogenous peroxidase activity. An Ultrasensitive TM S-P kit for immunocytochemical staining was used, with non-specific binding sites being blocked with normal goat serum. A rabbit polyclonal anti-(human NF-κB) antibody (Abcam) was added at a dilution of 1:100 and incubated overnight at 4
• C. After washing, cells were incubated for 1 h at 37
• C with biotinylated goat anti-(rabbit IgG) conjugated with a streptavidin-biotin-peroxidase complex for 20 min. DAB (3,3 -diaminobenzidine) was used as a substrate and cells were counterstained with Mayer's haematoxylin. The primary antibody was replaced with PBS as the negative control. Images of seven high power fields were acquired, and 200 cells were counted randomly with an Olympus BX51 microscope. Quantitative analyses of immunopositive cells was determined using MetaMorph 4.5 software.
ELISA for NF-κB p65 DNA-binding activity Nuclear proteins from transfection cells were extracted and determined as described above. To evaluate the nuclear activity of the activated NF-κB p65 subunit, the ELISA-based Trans-AM TM assay (ActiveMotif) was used as follows. A portion (15 μg) of nuclear protein was diluted in 20 μl of lysis buffer and loaded into a 96-well plate containing an NF-κB p65 consensus-binding site (5 -GGGACTTTCC-3 ) . After shaking at 100 rev./min for 1 h, 100 μl of anti-(NF-κB p65) antibody was added and incubated for 1 h. Then, 100 μl of HRP-conjugated secondary antibody was added and incubated for 1 h. Reaction buffer (100 μl) was added and incubated for 2-10 min, followed by stop buffer. The absorbance was measured by spectrophotometry over 5 min at 450 nm. Nuclear protein (2.5 μg) from Jurkat cells was used as positive control, and 20 μl of complete lysis buffer was used as empty control. To monitor the specificity, WT (wild-type) and MT (mutated-type) oligonucleotides were used as competitors for NF-κB binding.
Statistic analysis
Results are expressed as means + − S.D. One-way ANOVA, followed by the Tukey test, was performed using SPSS 12.0. Deviations were considered statistically significant when P < 0.05.
RESULTS
Inhibition efficiency of psiRNA-hH1DEK and psiRNA-IκB
Compared with untransfected and CaSki-neo cells, the levels of DEK and IκBα mRNA and protein declined predominantly in CaSki-DEK and CaSki-IκB cells respectively. The inhibitory efficiency of DEK mRNA and protein were 64.2 and 68.3 % (Figure 1 ), which were statistically different compared with the controls (P < 0.05). The inhibitory efficiencies of IκBα mRNA and protein were 72.5 and 63.9 % (Figure 2 ), which were statistically different compared with the controls (P < 0.05). There were no obvious differences in untransfected and CaSki-neo cells(P > 0.05) (Figures 1 and 2 ).
DEK and IκBα shRNA inhibit cell proliferation
As observed under an inverted phase-contrast microscope, CaSki-DEK cells had a flattened and enlarged appearance, more detached cells and floating particles, and increased vacuoles in the cytoplasm. These observations implied that the silencing of DEK had effects on the growth of CaSki. The cell growth curve showed that, compared with untransfected and CaSki-neo cells, the proliferation activity of CaSki-DEK cells was inhibited in a time-dependent manner ( Figure 3) . The A 570 of CaSki-DEK cells at different time intervals was lower than that of control cells, which was statistically significant (P < 0.05). The A 570 of CaSki-IκB cells at different time intervals was also lower than that of 
DEK and IκBα shRNA induces apoptosis and blocks the cell cycle
With the inhibition of DEK, the percentage of apoptotic cells in CaSki-DEK cells was higher than those in control cells (P < 0.05) ( Table 1 and Figure 4) . The apoptotic rate in CaSki-IκB cells was also higher than that of control cells (P < 0.05) ( Table 1 and Figure 4) . However, there was no difference between CaSki-DEK and CaSki-IκB cells (P > 0.05). In CaSki-DEK and CaSki-IκB cells, more cells were blocked in the G 0 /G 1 -phase, with a corresponding decrease in the G 2 /M-phase (Table 1 and Figure 5 ). The percentage of cells in the G 0 /G 1 -phase was significantly increased in CaSki-DEK and CaSki-IκB cells compared with control cells (P < 0.05).
Induction of cell senescence by DEK and IκBα shRNA
As shown in Figure 6 senescence, whereas only a few positively stained cells were detected in untransfected cells. As measured by microscopic image analysis, the percentage of positive staining was 83.25 + − 9.46 % in CaSki-DEK cells and 76.47 + − 6.31 % in CaSki-IκB cells, whereas the positive staining in CaSki-neo and untransfected cells was 23.13 + − 7.28 and 18.92 + − 6.46 % respectively. There was a statistical significance between CaSki-DEK and control cells (P < 0.05); however, there was no difference between CaSki-DEK and CaSki-IκB cells. These findings suggested that the CaSki cells were induced into a senescent state by the silencing of DEK or IκBα.
Activation and translocation of NF-κB p65 with DEK shRNA transfection
The expression levels of NF-κB p65, p50, c-Rel, IκBα and phospho-IκBα protein were detected by immunoblotting after psiRNA-hH1DEK and psiRNA-IKB transfection (Figure 7 ). The expression of p50 and c-Rel in the cell lysates and the cytosolic fractions was similar in all of the cells. There was no statistical difference between CaSki-DEK, CaSki-IκB and control cells (P > 0.05). No p50 and c-Rel expression was detected in the nuclear fractions of cells. DEK shRNA induced the total degradation of IκBα and increased the level of phospho-IκBα in cell lysates and cytoplasmic extracts. There was a significant difference between CaSki-DEK and control cells (P < 0.05). The level of IκBα protein in the cell lysates and the cytoplasmic fraction was reduced after IκBα shRNA transfection. No hybridization signal of IκBα and phospho-IκBα was detected in the nuclear extracts of cells. Results from the Western blot analysis showed that the expression level of NF-κB p65 protein was almost equal in whole-cell lysates from control cells, whereas it was increased in nucleus and decreased in cytoplasm after DEK or IκBα shRNA transfection. These results indicated that both DEK and IκBα lead to a similar induction of the pathway for NF-κB p65 activation. To investigate whether other signal pathways were involved in DEK and IκBα depletion-induced apoptosis and senescence in CaSki cells, we studied their effects on the protein expression and kinase activity of p38 and JNK. It was shown that neither of them influenced the expression and kinase activity of p38 and JNK in CaSki cells. There was no statistical difference between CaSki-DEK, CaSki-IκB and control cells (P > 0.05).
The NF-κB activity determined by ELISA supported the findings observed by immunoblotting (Figure 8 ). CaSki-DEK and CaSki-IκB cells showed a significant increase in the activity of the NF-κB p65 subunit compared with control cells (P < 0.05). In accordance with this, in CaSki-neo and untransfected cells, NF-κB p65 was retained uniformly in the cytoplasm and only a mild-to-moderate expression was observed by immunocytochemical staining. In CaSki-DEK cells, NF-κB p65 was activated and translocated to the nucleus, with most cells having high nuclear staining (Figure 9 ). The percentage of positive cells in untransfected, CaSki-neo and CaSki-DEK cells was 15.72 + − 2.64, 21.63 + − 3.95 and 74.21 + − 8.16 % respectively (P < 0.05). These results demonstrate that DEK shRNA could activate NF-κB expression and promote nuclear translocation.
DISCUSSION
Cervical cancer is the most common gynaecologic malignancy in women and has a close relationship with infection by HPVs [12] . Approximately 30 types of genital HPVs have been found in cervix lesions, and are divided into high-risk and low-risk types [13] . The two viral oncogenes, E6 and E7, of high-risk HPV interact with proto-oncogenes and tumour suppressor genes in their host and play an important role in carcinogenesis and . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . progression [14] . The human DEK proto-oncogene can be transcriptionally up-regulated by HPV E7, and increased expression has been found in cervical cancers, the expression of which is related to the differentiation grade of the cancer [15] . DEK is a potential target for early diagnosis and therapy in cervical cancers.
Regarding the clinical significance of DEK in cervical cancer, the mechanisms and function of it remain unexplored.
Overexpression of DEK has been found in multiple human diseases [16, 17] , and research has focused on its role in apoptosis and senescence regulation [2, 3] . It has been shown that apoptosis and senescence play an important role in carcinogenesis and the development of cervical cancer [18] . It is suggested that DEK may be a pivotal gene in the diagnosis and treatment of cervical cancer. Since the original discovery of RNAi (RNA interference) mechanisms in mammalian cells [19] , it has become a powerful and favourite tool in tumour biology and functional genomics studies. Compared with traditional antisense and knockdown technology, RNAi appears to be more specific and efficient, and may be a promising tool in gene therapy [20] . In the present study, we constructed a DEK shRNA to investigate its role and mechanism in cervical cancer. After selection with G418, a stable cell line containing the silencing of the DEK gene was obtained, and the expression of DEK mRNA and protein was suppressed by 64.17 and 68.32 % respectively. In accordance with previous studies, DEK repression resulted in the induction of apoptosis and senescence of CaSki cells. The apoptosis rate and the percentage of cells in G 0 /G 1 -phase increased, whereas the S-phase fraction and proliferation index decreased with the inhibition of DEK. The MTT assay indicated that cell proliferation was inhibited compared with parental cells and the empty vector group. The morphology of CaSki-DEK cells underwent changes characteristic of senescence, and the majority of them showed intense senescenceassociated β-galacactosidase activity. Taken together, the reduction in DEK expression was sufficient to induce most CaSki cells into senescence, whereas others were prone to apoptosis. The dual role of NF-κB in enhancing or inhibiting apoptosis and cell death has attracted much attention in regard to its role in carcinogenesis [21] . In resting cells, NF-κB resides in the cytoplasm as an inactive heterodimer composed of p50 and p65 subunits interacting with a member of the inhibitory IκB family [22] . Upon stimulation by activating signals, such as TNF-α (tumour-necrosis factor-α), growth factors, oxidative stress, viruses and bacteria [23] , IκB proteins are phosphorylated and trigger ubiquitin-dependent degradation, resulting in the translocation of NF-κB to the nucleus and the activated transcription of binding target genes. Activation of the NF-κB pathway is suggested to be associated with HPV-induced human cervical carcinoma [24] . In normal cervical tissue, almost 50 % of the samples showed a mild-to-moderate uniform cytoplasmic expression of the NF-κB p65 subunit across the epithelium, but the nuclear localization was negligible [25] . In more than half of squamous cell carcinoma, the NF-κB p65 subunit was upregulated and distributed equally in the cytoplasm and nucleus [8] . We have detected the up-regulation of DEK and activation of the NF-κB pathway in cervical intraepithelial neoplasm and cervical cancer by RT-PCR and Western blot (results not shown). DEK enriches transcriptionally active chromatin combined with specific transcription factor complexes and has a dual role as a transcriptional co-activator and co-repressor. It can interact with some transcriptional repressor proteins, including HDAC2, Daxx, the peri-Ets (pets) site in the HIV-2 promoter, P/CAF [p300/CREB (cAMP-response-element-binding protein)-binding protein-associated factor] and p300/CBP (p300/CREBbinding protein), resulting in decreased levels of transcription [26, 27] . In addition, DEK expression also repressed the ability of the androgen receptor, p53 and STAT5B (signal transducer and activator of transcription 5B) to activate transcription [28] . Furthermore, DEK was shown to interact with the AP-2α (activator protein 2α) transcription factor to enhance its ability to activate transcription. The acetylation of DEK by the P/CAF transcriptional co-activator within its N-terminus displaces DEK from promoters to allow transcriptional activation [29] . DEK functions as a transcriptional co-repressor protein to negatively regulate NF-κB-dependent gene expression in a concentration-dependent manner. It represses NF-κB through the p65 transactivation domain or binding directly to DNA [30] . On the basis of the functional linkage between DEK and NF-κB, we suggested that the NF-κB pathway may be involved in senescence and apoptosis regulated by DEK. In the present study, the expression levels of NF-κB p65, p50, c-Rel, IκBα and phospho-IκBα proteins in the cell lysate, cytoplasm and nucleus were detected by Western blot analysis. With the reduction in DEK, NF-κB p65 was activated and translocated to a nuclear localization. In addition, the DNA-binding activity of the NF-κB p65 subunit was significantly increased with the inhibition of DEK. An shRNA plasmid of IκBα was transfected into CaSki cells and recapitulated the DEK-silenced phenotype, including the inhibition of proliferation, induction of apoptosis and senescence and blockage of the cell cycle by activating p65. All of the results indicated that both DEK and IκBα lead to a similar induction pathway of p65 activation, whereas the activities of the p50 and c-Rel subunits did not change. The effects of DEK and IκBα shRNA on the protein expression and kinase activity of p38 and JNK were studied at the same time. The results showed that neither of them influenced the expression and kinase activity of p38 and JNK in CaSki cells. There was no statistical difference between CaSki-DEK, CaSki-IκB and control cells (P > 0.05). Thus these experiments have shown that the specific modulation of p65 activity is in itself sufficient to induce the observed effects on proliferation, cell growth and apoptosis in CaSki cells with DEK silencing.
In summary, our results demonstrate that DEK inhibition results in a significant growth repression of CaSki cells by inducing cell apoptosis and senescence. The NF-κB pathway is upregulated in response to the reduction in DEK. Defining the cellular pathways downstream of DEK that influence senescence compared with apoptosis, together with a more detailed understanding of the involvement of NF-κB, will be an important task for the future.
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